Correlation Between Fairfax Financial and Medipharm Labs
Can any of the company-specific risk be diversified away by investing in both Fairfax Financial and Medipharm Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fairfax Financial and Medipharm Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fairfax Financial Holdings and Medipharm Labs Corp, you can compare the effects of market volatilities on Fairfax Financial and Medipharm Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fairfax Financial with a short position of Medipharm Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fairfax Financial and Medipharm Labs.
Diversification Opportunities for Fairfax Financial and Medipharm Labs
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Fairfax and Medipharm is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Fairfax Financial Holdings and Medipharm Labs Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medipharm Labs Corp and Fairfax Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fairfax Financial Holdings are associated (or correlated) with Medipharm Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medipharm Labs Corp has no effect on the direction of Fairfax Financial i.e., Fairfax Financial and Medipharm Labs go up and down completely randomly.
Pair Corralation between Fairfax Financial and Medipharm Labs
Assuming the 90 days trading horizon Fairfax Financial Holdings is expected to generate 0.34 times more return on investment than Medipharm Labs. However, Fairfax Financial Holdings is 2.93 times less risky than Medipharm Labs. It trades about 0.2 of its potential returns per unit of risk. Medipharm Labs Corp is currently generating about -0.03 per unit of risk. If you would invest 1,767 in Fairfax Financial Holdings on October 23, 2024 and sell it today you would earn a total of 463.00 from holding Fairfax Financial Holdings or generate 26.2% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Fairfax Financial Holdings vs. Medipharm Labs Corp
Performance |
Timeline |
Fairfax Financial |
Medipharm Labs Corp |
Fairfax Financial and Medipharm Labs Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fairfax Financial and Medipharm Labs
The main advantage of trading using opposite Fairfax Financial and Medipharm Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fairfax Financial position performs unexpectedly, Medipharm Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medipharm Labs will offset losses from the drop in Medipharm Labs' long position.Fairfax Financial vs. Nicola Mining | Fairfax Financial vs. Broadcom | Fairfax Financial vs. Bird Construction | Fairfax Financial vs. Lion One Metals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |